Evaluating the addition of bevacizumab to endocrine therapy as first-line treatment for hormone receptor–positive metastatic breast cancer: a pooled analysis from the LEA (GEICAM/2... von Martín, M., Loibl, S., Hyslop, T., De la Haba-Rodríguez, J., Aktas, B., Cirrincione, C.T., Mehta, K., Barry, W.T., Morales, S., Carey, L.A., Garcia-Saenz, J.A., Partridge, A., Martinez-Jañez, N., Hahn, O., Winer, E., Guerrero-Zotano, A., Hudis, C., Casas, M., Rodriguez-Martin, C., Furlanetto, J., Carrasco, E., Dickler, M.N.

Volltext

A survey of female cancer patients’ awareness of and preferences for receiving sexual health interventions von Stabile, C, Zabor, E.C, Baser, R.E, Goldfarb, S, Goldfrank, D.J, Dickler, M.N, Abu-Rustum, N.R, Barakat, R.R

Volltext

A single-arm clinical trial investigating the effectiveness of a non-hormonal vaginal moisturizer in postmenopausal cancer survivors von Carter, J., Goldfarb, S., Baser, R.E., Goldfrank, D.J., Seidel, B., Milli, L., Stabile, C., Canty, J., Dickler, M.N., Alektiar, K.

Volltext

Analysis of overall survival by tumor response in MONARCH 1, a phase 2 study of abemaciclib, a CDK4 and CDK6 inhibitor, in women with HR+/HER2- metastatic breast cancer (MBC) after... von Cortés, J., Rugo, H.S., Tolaney, S.M., Diéras, V., Patt, D., Wildiers, H., Nanda, S., Koustenis, A., Dickler, M.N., Baselga, J.

Volltext

Phase II study of gemcitabine, trastuzumab, and pertuzumab for HER2-positive metastatic breast cancer after prior pertuzumab-based therapy von Iyengar, N.M., Smyth, L.M., Lake, D., Gucalp, A., Singh, J.C., Traina, T.A., Defusco, P., Dickler, M.N., Fornier, M.N., Goldfarb, S.B., Jhaveri, K., Modi, S., Troso-Sandoval, T., Jack, K., Ulaner, G., Jochelson, M., Baselga, J., Norton, L., Hudis, C.A., Dang, C.T.

Volltext

biomarkers Exploratory biomarkers in MONARCH 1, a phase II study of abemaciclib monotherapy in hormone-receptor positive (HR ) HER2- metastatic breast cancer (MBC) von Tolaney, S.M., Cortes, J., Dickler, M.N., Zamora, E., Caldwell, C.W., Nguyen, T.S., Nanda, S., Koustenis, A., Rugo, H.S.

Volltext

A Phase I dose-escalation study of the VEGFR inhibitor tivozanib hydrochloride with weekly paclitaxel in metastatic breast cancer von Mayer, Erica L., Scheulen, M. E., Beckman, J., Richly, H., Duarte, A., Cotreau, M. M., Strahs, A. L., Agarwal, S., Steelman, L., Winer, E. P., Dickler, M. N.

Volltext

Phase II study of gemcitabine, trastuzumab, and pertuzumab for HER2-positive metastatic breast cancer after prior pertuzumab-based therapy von Iyengar, N.M., Smyth, L., Lake, D., Gucalp, A., Singh, J., Traina, T.A., Defusco, P., Dickler, M.N., Fornier, M., Goldfarb, S., Jhaveri, K., Latif, A., Modi, S., Troso-Sandoval, T., Ulaner, G., Jochelson, M., Baselga, J., Norton, L., Hudis, C., Dang, C.

Volltext

A phase 1b study of abemaciclib, an inhibitor of CDK4 and CDK6, in combination with endocrine and HER2-targeted therapies for patients with metastatic breast cancer von Beeram, M., Tolaney, S.M., Beck, J.T., Dickler, M.N., Conlin, A.K., Dees, C., Helsten, T.L., Conkling, P.R., Edenfield, W.J., Richards, D.A., Kambhampati, S.R.P., Costigan, T.M., Chan, E., Pant, S., Kalinsky, K., Burris, H.A., Becerra, C.H., Rexer, B.N., Puhalla, S.L., Goetz, M.P.

Volltext

Heterogeneity of Genomic Fusion of BCR and ABL in Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia von Rubin, Charles M., Carrino, John J., Dickler, Maura N., Leibowitz, David, Smith, Stephen D., Westbrook, Carol A.

Volltext

A deletion/insertion polymorphism in the human BCR gene on chromosome 22 von RUBIN, C. M, BLAZAR, B. R, HOOBERMAN, A. L, DICKLER, M. N, MILLER, B. A, WESTBROOK, C. A

Volltext

Phase II Study of Paclitaxel and Dasatinib in Metastatic Breast Cancer von Morris, Patrick G., Rota, Selene, Cadoo, Karen, Zamora, Stephen, Patil, Sujata, D'Andrea, Gabriella, Gilewski, Theresa, Bromberg, Jacqueline, Dang, Chau, Dickler, Maura, Modi, Shanu, Seidman, Andrew D., Sklarin, Nancy, Norton, Larry, Hudis, Clifford A., Fornier, Monica N.

Volltext

A phase I study of dasatinib and weekly paclitaxel for metastatic breast cancer von Fornier, M.N., Morris, P.G., Abbruzzi, A., D'Andrea, G., Gilewski, T., Bromberg, J., Dang, C., Dickler, M., Modi, S., Seidman, A.D., Sklarin, N., Chang, J., Norton, L., Hudis, C.A.

Volltext